Inventiva SA (IVA) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Inventiva SA (IVA) following the 2026 Q2 hedge fund 13F filings?

As of today, IVA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), IVA gained +21.7% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Inventiva SA (IVA)

66 + Investors. Track Smart Money conviction in IVA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — IVA

Based on 66 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 5 quarters in a row

last 6Q

For 5 consecutive quarters, more hedge funds added IVA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

66 hedge funds hold IVA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +725% more funds vs a year ago

fund count last 6Q

+58 new funds entered over the past year (+725% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 69% buying

44 buying20 selling

Last quarter: 44 funds were net buyers (23 opened a brand new position + 21 added to an existing one). Only 20 were sellers (10 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

⚠️

Fewer new buyers each quarter (-15 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 4 → 5 → 38 → 23. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔄

Mostly new holders — 79% entered in last year

■ 12% conviction (2yr+) ■ 9% medium ■ 79% new

Only 8 funds (12%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +34% but shares only +12% — price-driven

Value

+33%

+12%

Last quarter: the total dollar value of institutional holdings rose +34%, but actual share count only changed +12%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

1 → 4 → 5 → 38 → 23 new funds/Q

New funds entering each quarter: 4 → 5 → 38 → 23. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 79% of holders entered in last year

■ 18% veterans ■ 3% 1-2yr ■ 79% new

Of 66 current holders: 52 (79%) entered in the past year, only 12 (18%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 18% AUM from top-100

18% from top-100 AUM funds

11 of 66 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

7.0

out of 10

High Exit Risk

Exit risk score 7.0/10 — multiple crowding signals converge. Institutional ownership is at 100% of its all-time high — near peak crowding. Crowded trades can unwind fast — a single catalyst can trigger a cascade.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	66	53	24.53%
13F Shares	52M	47M	12.1%
Total Value	$290M	$217M	33.61%
New Positions	23	38	-15
Increased Positions	21	6	+15
Closed Positions	10	0	+10
Reduced Positions	10	1	+9
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

24.53%

13F Shares

52M

47M

12.1%

Total Value

$290M

$217M

33.61%

New Positions

-15

Increased Positions

+15

Closed Positions

+10

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

66 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IVA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 IVA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Andera Partners	6.65%	3,633,181	$13.7M
2	Yu Fan	5.25%	1,500,000	$5.7M
3	NEXTBio Capital Management LP	3.11%	1,787,984	$6.8M
4	Squadron Capital Management LLC	2.86%	2,435,000	$9.2M
5	Propel Bio Management, LLC	2.53%	1,281,212	$4.8M
6	Ally Bridge Group (NY) LLC	2.12%	634,800	$2.4M
7	Samsara BioCapital, LLC	1.96%	6,314,805	$23.9M
8	Trails Edge Capital Partners, LP	1.60%	2,657,997	$10.0M
9	Caligan Partners LP	1.45%	8,163,191	$30.9M
10	Patient Square Capital LP	1.15%	1,967,171	$7.4M
11	Stempoint Capital LP	0.93%	1,426,320	$5.4M
12	HighVista Strategies LLC	0.72%	831,442	$3.1M
13	ADAR1 Capital Management, LLC	0.62%	3,606,656	$13.6M
14	Kingdon Capital Management, L.L.C.	0.49%	1,270,000	$4.8M
15	Ikarian Capital, LLC	0.45%	1,129,101	$4.2M
16	NEA Management Company, LLC	0.35%	1,462,586	$5.5M
17	Diadema Partners LP	0.34%	740,786	$2.7M
18	Nantahala Capital Management, LLC	0.34%	2,686,393	$10.2M
19	Paradigm Biocapital Advisors LP	0.28%	4,000,000	$15.1M
20	Persistent Asset Partners Ltd	0.24%	209,182	$791K
21	Integral Health Asset Management, LLC	0.23%	1,520,000	$5.7M
22	Boothbay Fund Management, LLC	0.10%	2,003,782	$7.6M
23	Bvf Inc/Il	0.07%	686,040	$2.6M
24	R Squared Ltd	0.06%	29,918	$113K
25	Ground Swell Capital, LLC	0.05%	12,803	$48K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Inventiva SA (IVA)

What does the Smart Money Trend signal show for IVA?

Buying streak — 5 quarters in a row: For 5 consecutive quarters, more hedge funds added IVA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IVA?

More buyers than sellers — 69% buying: Last quarter: 44 funds were net buyers (23 opened a brand new position + 21 added to an existing one). Only 20 were sellers (10 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IVA holders?

Smaller funds dominant — 18% AUM from top-100: 11 of 66 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held IVA?

Mostly new holders — 79% entered in last year: Only 8 funds (12%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Inventiva SA (IVA) following the 2026 Q2 hedge fund 13F filings?

As of today, IVA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), IVA has gained +21.7% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Inventiva SA (IVA)

Smart Money Signals — IVA

Buying streak — 5 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +725% more funds vs a year ago

More buyers than sellers — 69% buying

Fewer new buyers each quarter (-15 vs last Q)

Mostly new holders — 79% entered in last year

Value +34% but shares only +12% — price-driven

Acceleration phase — new buyers rushing in

Early stage — 79% of holders entered in last year

Smaller funds dominant — 18% AUM from top-100

Institutional Sentiment Summary — IVA

Hedge Fund Ownership: IVA

Market Analysis: IVA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: IVA

Is It Too Late to Buy Inventiva SA (IVA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: IVA

Statistics: IVA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Inventiva SA (IVA)

Welcome to 13Foresight!